BR112018016050A2 - estruturas de paredes celulares descelularizadas provenientes de plantas e fungos e uso das mesmas como materiais de scaffold - Google Patents

estruturas de paredes celulares descelularizadas provenientes de plantas e fungos e uso das mesmas como materiais de scaffold

Info

Publication number
BR112018016050A2
BR112018016050A2 BR112018016050A BR112018016050A BR112018016050A2 BR 112018016050 A2 BR112018016050 A2 BR 112018016050A2 BR 112018016050 A BR112018016050 A BR 112018016050A BR 112018016050 A BR112018016050 A BR 112018016050A BR 112018016050 A2 BR112018016050 A2 BR 112018016050A2
Authority
BR
Brazil
Prior art keywords
tissue
fungi
plants
cell wall
scaffold
Prior art date
Application number
BR112018016050A
Other languages
English (en)
Other versions
BR112018016050B1 (pt
Inventor
Edward Pelling Andrew
Michel Cuerrier Charles
J Modulevsky Daniel
Joseph Hickey Ryan
Original Assignee
Univ Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ottawa filed Critical Univ Ottawa
Publication of BR112018016050A2 publication Critical patent/BR112018016050A2/pt
Publication of BR112018016050B1 publication Critical patent/BR112018016050B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3637—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a invenção se refere a biomateriais de scaffold compreendendo um tecido vegetal ou fúngico do qual materiais celulares e ácidos nucléicos do tecido são removidos, o tecido vegetal ou fúngico compreendendo uma estrutura porosa tridimensional baseada em celulose ou quitina. a invenção também se refere a métodos para preparar esses biomateriais de scaffold, bem como os usos dos mesmos como um scaffold implantável para suportar o crescimento celular animal, para promover a regeneração do tecido celular, para promover a angiogênese, para um procedimento de substituição de tecido, e/ou como um implante estrutural para cirurgia estética. adicionalmente são descritos tratamento terapêutico e/ou métodos cosméticos empregando tais scaffolds.
BR112018016050-4A 2016-02-12 2017-02-10 Biomaterial de estrutura tridimensional, método para preparar um tecido vegetal descelularizado, uso do biomaterial de estrutura tridimensional, e, kit BR112018016050B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662294671P 2016-02-12 2016-02-12
US62/294.671 2016-02-12
PCT/CA2017/050163 WO2017136950A1 (en) 2016-02-12 2017-02-10 Decellularised cell wall structures from plants and fungus and use thereof as scaffold materials

Publications (2)

Publication Number Publication Date
BR112018016050A2 true BR112018016050A2 (pt) 2018-12-26
BR112018016050B1 BR112018016050B1 (pt) 2022-04-12

Family

ID=59563678

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018016050-4A BR112018016050B1 (pt) 2016-02-12 2017-02-10 Biomaterial de estrutura tridimensional, método para preparar um tecido vegetal descelularizado, uso do biomaterial de estrutura tridimensional, e, kit

Country Status (11)

Country Link
US (3) US11045582B2 (pt)
EP (1) EP3413939B1 (pt)
JP (2) JP6957486B2 (pt)
CN (1) CN109152863A (pt)
AU (2) AU2017218476B2 (pt)
BR (1) BR112018016050B1 (pt)
CA (1) CA3014256C (pt)
ES (1) ES2953657T3 (pt)
IL (2) IL260993B (pt)
MX (1) MX2018009551A (pt)
WO (1) WO2017136950A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9485917B2 (en) 2006-12-15 2016-11-08 Ecovative Design, LLC Method for producing grown materials and products made thereby
US11277979B2 (en) 2013-07-31 2022-03-22 Ecovative Design Llc Mycological biopolymers grown in void space tooling
US20150101509A1 (en) 2013-10-14 2015-04-16 Gavin R. McIntyre Method of Manufacturing a Stiff Engineered Composite
US11883275B2 (en) 2014-06-11 2024-01-30 Bard Shannon Limited In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
US11638640B2 (en) 2014-06-11 2023-05-02 Bard Shannon Limited In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
AU2017227612C1 (en) 2016-03-01 2023-02-16 The Fynder Group, Inc. Filamentous fungal biomats, methods of their production and methods of their use
US11359074B2 (en) 2017-03-31 2022-06-14 Ecovative Design Llc Solution based post-processing methods for mycological biopolymer material and mycological product made thereby
WO2018200753A1 (en) * 2017-04-25 2018-11-01 Paul Gatenholm Biocompatible conductive inks based on cellulse nanofibrils for 3d printing of conductive biomedical devices
TWI612966B (zh) * 2017-06-06 2018-02-01 景鑫生物科技股份有限公司 南洋山蘇水萃物的用途
US11266085B2 (en) 2017-11-14 2022-03-08 Ecovative Design Llc Increased homogeneity of mycological biopolymer grown into void space
US11844683B2 (en) 2018-03-12 2023-12-19 Bard Shannon Limited In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
US11920126B2 (en) 2018-03-28 2024-03-05 Ecovative Design Llc Bio-manufacturing process
US11293005B2 (en) 2018-05-07 2022-04-05 Ecovative Design Llc Process for making mineralized mycelium scaffolding and product made thereby
US11343979B2 (en) 2018-05-24 2022-05-31 Ecovative Design Llc Process and apparatus for producing mycelium biomaterial
CN112714788A (zh) * 2018-07-23 2021-04-27 生态创新设计有限责任公司 生产真菌产品的方法和由此制备的产品
US11110203B2 (en) * 2018-08-22 2021-09-07 Worcester Polytechnic Institute Decellularization of plant cell culture materials for tissue engineering and drug delivery
US11359174B2 (en) 2018-10-02 2022-06-14 Ecovative Design Llc Bioreactor paradigm for the production of secondary extra-particle hyphal matrices
SG11202105283PA (en) * 2018-11-20 2021-06-29 Ecovative Design Llc Methods of generating mycelial scaffolds and applications thereof
CN111494722B (zh) * 2019-01-31 2023-06-23 华东理工大学 干细胞发生器制备骨缺损修复材料的新用途
US20220142907A1 (en) * 2019-03-13 2022-05-12 Ecovative Design Llc Mycelium biopolymers for health and beauty applications
CN110257335B (zh) * 2019-04-10 2020-09-29 首都医科大学附属北京天坛医院 单层或多层的3d脑胶质瘤细胞培养模型及其构建方法和应用
JP2022533973A (ja) * 2019-05-14 2022-07-27 スパイダーワート インク． 複合生体材料
MX2021013859A (es) * 2019-05-14 2022-03-22 Spiderwort Inc Microcanales de alta densidad.
US20220236255A1 (en) * 2019-06-28 2022-07-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Self-Contained Responsive Biological Systems and Methods
KR102334114B1 (ko) * 2019-11-25 2021-12-02 영남대학교 산학협력단 진균을 이용한 스캐폴드 제조 및 이를 이용한 조직 재생방법
WO2021119830A1 (en) * 2019-12-19 2021-06-24 Spiderwort Inc. Biomaterials for bone tissue engineering
KR102151203B1 (ko) * 2019-12-19 2020-09-02 주식회사 씨위드 세포 배양용 지지체 및 그 제조 방법
BR122023021841A2 (pt) 2020-03-23 2024-02-20 Bard Shannon Limited Prótese implantável que compreende estrutura de material biocompatível
WO2021231372A1 (en) * 2020-05-11 2021-11-18 Worcester Polytechnic Institute Non-decellularized plant leaf cultures for meat
AU2021287463A1 (en) * 2020-06-08 2023-01-05 Spiderwort Inc. Dermal fillers
CN111982629B (zh) * 2020-08-25 2023-11-17 北京市农林科学院 一种食用菌组织细胞的超薄冷冻切片方法
CA3197332A1 (en) * 2020-11-12 2022-05-19 Jessica T. HOLMES Porous scaffold, method of making and uses thereof
KR20220161212A (ko) * 2021-05-28 2022-12-06 주식회사 씨위드 세포 배양용 지지체
CN113908336B (zh) * 2021-09-29 2022-11-04 重庆医科大学附属口腔医院 一种溶菌酶相转变膜改性纤维素支架及其制备方法和用途
CN114134048B (zh) * 2021-11-23 2023-09-05 广西壮族自治区药用植物园 一株内生真菌及其应用于桑寄生繁育中的方法和其用途
WO2023102083A1 (en) * 2021-12-01 2023-06-08 Luyef Biotechnologies Inc. Methods for creating edible scaffolding using chilean seaweed (cochayuyo)
CN115068686A (zh) * 2022-05-18 2022-09-20 复旦大学附属中山医院 一种天然来源的黑磷-丝蛋白-纤维素生物支架
CN114836371B (zh) * 2022-06-14 2023-02-24 南京鼓楼医院 一种基于植物脱细胞支架的组织工程肝脏和制备方法
CN115227868B (zh) * 2022-07-20 2023-07-07 中南大学湘雅医院 骨缺损修复材料及镁预处理脱细胞组织工程骨支架
WO2024026560A1 (en) * 2022-08-01 2024-02-08 Blue Solutions Canada Inc. Multifunctionalized thiol conductor compound and method for making same
CN115216441B (zh) * 2022-08-03 2024-03-19 华中农业大学 一种用于干细胞三维培养的复合支架及其制备方法
CN116173300B (zh) * 2022-11-21 2023-08-22 郑州大学第一附属医院 一种植物脱细胞人工血管及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006220565A1 (en) * 2005-03-07 2006-09-14 Georgia Tech Research Corporation Nanofilament scaffold for tissue regeneration
JP2006289062A (ja) 2005-03-18 2006-10-26 Pentax Corp 肥大化能を有する軟骨細胞と足場を用いた骨補填材料
EP2347774B1 (en) * 2005-12-13 2017-07-26 The President and Fellows of Harvard College Scaffolds for cell transplantation
GB2466073A (en) 2008-12-12 2010-06-16 Univ Manchester Tissue repair scaffold
WO2011123798A2 (en) 2010-04-01 2011-10-06 The Johns Hopkins University Three-dimensional scaffolds, methods for fabricating the same, and methods of treating a peripheral nerve or spinal or spinal cord injury
WO2011124709A1 (en) 2010-04-08 2011-10-13 Qiagen Gmbh Chromatographic device and method for isolating and purifying nucleic acids
WO2013096741A2 (en) * 2011-12-23 2013-06-27 Anthrogenesis Corporation Organoids comprising decellularized and repopulated placental vascular scaffold
GB201212771D0 (en) * 2012-07-18 2012-08-29 Northwick Park Inst For Medcal Res Ltd Implant and method for producing an implant
KR102282769B1 (ko) * 2013-03-15 2021-07-29 미로매트릭스 메디칼 인크. 탈세포화된 기관 및 조직에 대한 마이크로입자 및 내피 세포의 용도
GB201310773D0 (en) * 2013-06-17 2013-07-31 Northwick Park Inst For Medcal Res Ltd Implant and method of producing an implant

Also Published As

Publication number Publication date
AU2017218476A1 (en) 2018-09-27
AU2022200696B2 (en) 2023-09-28
US11045582B2 (en) 2021-06-29
EP3413939C0 (en) 2023-06-07
JP6957486B2 (ja) 2021-11-02
WO2017136950A1 (en) 2017-08-17
ES2953657T3 (es) 2023-11-15
US20210001007A1 (en) 2021-01-07
CA3014256C (en) 2024-04-23
MX2018009551A (es) 2019-05-06
IL284915A (en) 2021-08-31
JP2019509723A (ja) 2019-04-11
US20190060520A1 (en) 2019-02-28
EP3413939B1 (en) 2023-06-07
EP3413939A1 (en) 2018-12-19
CA3014256A1 (en) 2017-08-17
US20220016317A1 (en) 2022-01-20
US11167062B2 (en) 2021-11-09
BR112018016050B1 (pt) 2022-04-12
CN109152863A (zh) 2019-01-04
IL260993B (en) 2021-08-31
AU2017218476B2 (en) 2022-02-17
IL284915B (en) 2022-02-01
JP2022002536A (ja) 2022-01-11
AU2022200696A1 (en) 2022-02-24
EP3413939A4 (en) 2019-10-30

Similar Documents

Publication Publication Date Title
BR112018016050A2 (pt) estruturas de paredes celulares descelularizadas provenientes de plantas e fungos e uso das mesmas como materiais de scaffold
BR112021022917A2 (pt) Biomateriais compósitos
BR112021006348A2 (pt) andaime para dispositivos médicos implantáveis e mé-todos de uso dos mesmos
BR112021025928A2 (pt) Métodos de preparação de ácido bempedoico e composições do mesmo
AU2018338608A1 (en) Methods, compositions, and implantable elements comprising active cells
WO2017069789A8 (en) Bone foundation guide system and method
BR112012019369A2 (pt) fabricação de enxerto de nervo biológico construído e aplicação do mesmo.
BR112019023409A2 (pt) Métodos para tratar um câncer em um paciente e uma malignidade hematológica, para expandir linfócitos infiltrantes de tumor, linfócitos de sangue periférico e linfócitos infiltrantes de medula, processo para a preparação de uma população de linfócitos infiltrantes de tumor, e, uso de um tumor líquido na fabricação de uma população de linfócitos infiltrantes de tumor.
CO2017010006A2 (es) Nuevos derivados de imidazolilmetilo 5–sustituidos
WO2006138718A3 (en) Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices
WO2014004746A3 (en) Methods and compositions for promoting the structural integrity of scaffolds for tissue engineering
BRPI0512831A (pt) construção de tecido liso, método para preparação de uma construção de tecido liso, uso da construção de tecido liso, e composição
EA201890516A1 (ru) Клинические композиции
BR112018070331A2 (pt) composições produzidas por micro-organismos tendo atividade estimulatória em plantas
BR112017025108A2 (pt) compostos seletivos de pyy e usos dos mesmos
BRPI0921726B8 (pt) método para preparar uma composição de implante para promover o crescimento ósseo em um mamífero
JP5474094B2 (ja) 放射線融合技術を用いた生体組織工学用β−グルカンベースの支持体およびその製造方法
DE602005025487D1 (de) Zellunabhängige herstellung von gewebeäquivalenten
CL2010001382A1 (es) Compuestos derivados de acido 1-heteroaril-pirazol -4 il acetico; su procedimiento de preparacion; agente herbicida que los contiene; procedimiento para la represion de plantas daninas; y uso de dichos compuestos para preparar composiciones herbicidas o reguladoras del crecimiento de las plantas.
BR112014031707A2 (pt) prótese; método para fabricar uma prótese implantável; e método para tratamento
WO2009049568A3 (en) Anisotropic implant and its method of production
BR112022016550A2 (pt) Proteínas de ligação a flt3 e métodos de uso
BR112022008744A2 (pt) Ligante de il-2rss, ligante de il-2r¿c, composto de ligação a il-2r¿¿c, composição farmacêutica, método para tratar uma doença em um paciente, método para expandir células imunes, método de uma terapia celular, método para reforçar uma vacina, método para modificar a resposta imune e ácido nucleico
BR112022009826A2 (pt) Biomateriais para engenharia de tecido ósseo
BR102016007036A8 (pt) material de reparo de tecido derivado de pele de peixe e método de fabricação do mesmo

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/02/2017, OBSERVADAS AS CONDICOES LEGAIS.